- Home
- YMAT vs ADXN Comparison
YMAT vs ADXN Comparison
Compare YMAT & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YMAT | ADXN |
|---|---|---|
| Founded | 1970 | 2002 |
| Country | Taiwan | Switzerland |
| Employees | 65 | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9M | 8.6M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | YMAT | ADXN |
|---|---|---|
| Price | $2.22 | $5.95 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 6.6M | 3.3K |
| Earning Date | 05-13-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $86.57 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $10.92 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.24 | $5.41 |
| 52 Week High | $6.45 | $12.05 |
Technical Indicators
Market Signals| Indicator | YMAT | ADXN |
|---|---|---|
| Relative Strength Index (RSI) | 70.66 | 50.38 |
| Support Level | $0.33 | $5.75 |
| Resistance Level | $2.47 | $7.37 |
| Average True Range (ATR) | 0.22 | 0.40 |
| MACD | 0.20 | 0.02 |
| Stochastic Oscillator | 71.45 | 46.75 |
Price Performance
Historical ComparisonAbout YMAT J-Star Holding Co. Ltd. Ordinary Shares
J-Star Holding Co Ltd is engaged in the research, development, and manufacturing of carbon fiber for a wide variety-of-products including carbon bicycles, carbon rackets, automotive parts, outdoor sports gears, and healthcare products. The company has five segments: Bicycle frame, Racket, Crank, Service provision, and Others. The majority of its revenue is generated from the Bicycle frame segment. Geographically, the company operates in Taiwan, China, and other regions.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.